1. Metalnikoff S. Etudes sur la spermotoxine. Ann Inst Pasteur 1900;9:577-589.

2. Besredka M. Les anti-hemolysines naturelles. Ann Inst Pasteur 1901;15:785-807.

3. Ehrlich P, Morgenroth J. On haemolysins: third communication. In: The Collected Papers of Paul Ehrlich, vol. 2. London: Pergamon Press, 1957;205-212.

4. Ehrlich P, Morgenroth J. On haemolysins: fifth communication. In: The Collected Papers of Paul Ehrlich, vol. 2. London: Pergamon Press, 1957;246-255.

5. Landsteiner K. The Specificity of Serological Reactions. Cambridge, Massachusetts: Harvard University Press CB 27, 1900;357-371.

6. Donath J, Landsteiner K. (1904) Über paroxysmale hamoglobinurie. Munch Med Wochenschr 1904;51:1590-1595.

7. Burnet FM, Fenner F. The production of antibodies. London: Macmillan, 1949.

8. Owen RD. (1945) Immunogenetic consequences of vascular anastomoses between bovine cattle twins. Science 1945;102:400-404.

9. Rose NR, Witebsky E. Studies on organ specificity: V changes in the thyroid glands of rabbits following acute immunization with rabbit tyroid extracts. J Immunol 1956;76:417^128.

10. Martin SE, Martin WJ. Interspecies brain antigen detected by naturally occurring mouse anti-brain autoantibody. Proc Natl Acad Sei USA 1975;72:1036-1041.

11. Martin WJ, Martin SE. Thymus reactive IgM autoantibodies in normal mouse sera. Nature 1975;254:716-718.

12. Sela BA, Wang JL, Edelman GM. Antibodies reactive with cell surface carbohydrates. Proc Natl Acad Sei USA 1975;72:1127-1132.

13. Mac Kay IR. Natural autoantibodies to the fore - forbidden clones to the rear?. Immunol Today 1983;4:340-342.

14. Izui S, Lambert PH, Founie GL. Features of systemic lupus erythematosus in mice infected with bacterial lipopolysaccharides. J Exp Med 1977;145:1115-1128.

15. Guilbert B, Dighiero G, Avrameas S. Naturally occurring antibodies against nine common antigens in human sera: I. Detection, isolation and characterization. J Immunol 1982;128:2779-2787.

16. Lutz HU, Wipf G. Naturally occurring autoantibodies to skeletal proteins from human red blood cells. J Immunol 1982;128:1695-1701.

17. Haspel MV, Onodera T, Prabhakar BS, McClin-tock KE, Ray UR, Yagihashi S, Notkins AL. Multi-

pie organ-reactive monoclonal autoantibodies. Nature 1983;304:74-76.

18. Dighiero G, Guilbert B, Avrameas S. Naturally occurring antibodies against nine common antigens in human sera: II. High incidence of monoclonal Ig exhibiting antibody activity against actin and tubulin and sharing antibody specificities with natural antibodies. J Immunol 1982;128:2788-2792.

19. Dighiero G, Guilbert B, Fermant JP, et al. Thirty-six human monoclonal immunoglobulins (MIg) with antibody activity against cytoskeleton proteins, thy-roglobulin and native DNA, immunological studies and clinical correlations. Blood 1983;62:264-270.

20. Dighiero G, Lymberi P, Mazié JC, Rouyre S, ButlerBrowne GS, Whalen RG, Avrameas S. Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J Immunol 1983:131:22672272.

21. Dighiero G, Lymberi P, Holmberg D, Lundquist I, Coutinho A, Avrameas S. High frequency of natural autoantibodies in normal newborn mice. J Immunol 1985;134:765-771.

22. Dighiero G. (1995) Natural autoantibodies in humans: their relevance in autoimmunity and lympho-proliferative disorders. Forum. Trends Exp Clin Med 1995;5:58-71.

23. Casali P, Notkins AL. Probing the human B-cell repertoire with EBV. Polyreactive antibodies and CD5+ B lymphocytes. Ann Rev Immunol. 1988;7:513-535.

24. Nemazee D, Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC Class antibody genes. Nature 1989;337:562-566.

25. Goodnow CC, Brink R, Adams E. Breakdown of self-tolerance in anergic B lymphocytes. Nature 1991;352:532-536.

26. Erikson J, Radie MZ, Camper SA, et al. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 1991;349:331-335.

27. Holmberg D, Forsgren S, Ivars F, et al. Reactions among IgM antibodies derived from normal, neonatal mice. Eur J Immunol 1984; 14:435^140.

28. Lymberi P, Dighiero G, Ternynck T, et al. A high incidence of cross-reactive idiotypes among murine natural autoantibodies. Eur J Immunol 1985;5:702-707.

29. Kearney JF, Vakil M. Idiotype directed interactions during ontogeny play a major role in the establishment of the adult B cell repertoire. Immunol Rev 1986;94:39-62.

30. Baccala R, Quang TV, Gilbert M, et al. Two murine natural polyreactive autoantibodies are encoded by nonmutated germ-line genes. Proc Natl Acad Sci USA 1989;86:4624-4628.

31. Gonzalez R, Charlemagne J, Mahana W, et al. Specificity of natural serum antibodies present in phylogeneticaly distinct fish species. Immunology 1988;63:31-36.

32. Du Pasquier L. Evolution of the immune system. In: William Paul, ed., Fundamental Immunology, 3rd edn. New York: Raven Press, 1993;199-235.

33. Seligmann M, Brouet JC. Antibody activity of human myeloma globulins. Semin Hematol 1973; 10:163177.

34. Williams RC, Kunkel HG, Capra JD. Antigenic specificities related to the cold agglutinin activity of gamma M globulins. Science 1968;161:379-384.

35. Pascual V, Victor K, Lelsz D, Spellerberg MB, Ham-blin TJ, Thompson KM, Randen I, Natvig J, Capra JD, Stevenson FK. Nucleotide sequence analysis of the V region of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype. J Immunol 1991 ;146:4385— 4392.

36. Silberstein LE, Jefferies LC, Goldman J, Friedman D, Moore JS, Nowell PC, Roelcke D, Pruzanski W, Roudier J, Silverman G. Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 1991;78:2372-2379.

37. Stevenson FK, Wrightham M, Glennie MJ, Jones DB, Cattan AR, Feizi T, Hamblin TJ, Stevenson GT. Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors. Blood 1986;68:430-437.

38. Potter KN, Li Y, Pascual V, Williams RC, Byres LC, Spellerberg M, Stevenson FK, Capra JD. Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segment. J Exp Med 1993;178:1419-1428.

39. Pruzanski W, Shumak KH. Biologic activity of cold reacting autoantibodies. N Engl J Med 1977;297:538-542.

40. Kritzman J, Kunkel HG, McCarthy J, Mellors RC. Studies of a Waldenström-type macroglobulin with rheumatoid factor properties. J Lab Clin Med 1961;57:905-912.

41. Crowley JJ, Goldfien RD, Schrohenlober RE, Spiegelberg HL, Silverman GJ, Mageed RA, Jefferis R, Koopman WJ, Carson DA, Fong S. Incidence of three cross-reactive idiotypes on human rheumatoid factor paraproteins. J Immunol 1988;140:3411-3418.

42. Agnello V, Joslin FG, Kunkel HG. Cross idiotypic specificity among monoclonal IgM anti-gammaglobulins. Scand J Immunol 1972;1:283-292.

43. Chen PP, Robbins DL, Jirik FR, Kipps TJ, Carson DA. Isolation and characterization of a light chain variable region gene for human rheumatoid factors. J Exp Med 1987;166:1900-1912.

44. Silverman GJ, Goni F, Fernandez J, Chen PP, Fran-gione B, Carson DA. Distinct patterns of heavy chain variable region subgroup use by human monoclonal autoantibodies of different specificity. J Exp Med 1988;168:2361-2366.

45. Silverman GJ, Schrohenholer RE, Achavitti MA, Koopman WJ, Carson DA. Structural characterization of the second major cross-reactive idiotype group of human rheumatoid factors: Association with the VH4 gene family. Arthritis Rheum 1990;33:1347-1360.

46. Dellagi K, Brouet JC, Danon F. Cross idiotypic antigens among monoclonal immunoglobulin M from patients with Waldenstrom's macroglobuline-mia and polyneuropathy. J Clin Invest 1979;64:1530-1539.

47. Shoenfeld Y, Amital Teplizki H, Mendlovic S, Blank M, Mozes E, Isenberg DA. The role of the human anti-DNA idiotype 16/6 in autoimmunity. Clin Immunol Immunopathol 1989;51:313-325.

48. Davidson A, Smith A, Katz J, Preud'homme JL, Salomon A, Diamond B. A cross-reactive idiotype on anti-DNA antibodies define a H chain determinant present almost exclusively on IgG antibodies. J Immunol 1989;143:174-180.

49. Bakkus MH, Van Riet I, Van Camp B, Thielemans K. Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. Br J Haematol 1994;87(1):68-74.

50. Saito T, Sherman W, Latov N. Specificity and idiotype of M-proteins that react with MAG in patients with neuropathy. J Immunol 130:2496-2502.

51. Brouet JC, Dellagi K, Gendron MC, Chevalier A, Schmitt C, Mihaesco E. Expression of a public idiotype by human monoclonal IgM directed to myelin-associated glycoprotein and characterization of the variability subgroup of their heavy and light chains. J Exp Med 1989;170:1551-1558.

52. Dighiero G, Travade P, Chevret S, Fenaux P, Chas-tang C, Binet JL. B-cell Chronic Lymphocytic Leukemia: Present status and future directions. Blood 1991;78:1901-1914.

53. Broker BM, Klajman A, Youinou P, Jouquan J, Wor-man CP, Murphy J, Mackenzie L, Quartey-Papafio R, Blaschek M, Collins P, Lai S, Lydyard PM. Chronic lymphocytic leukemic (CLL) cells secrete multispe-cific autoantibodies. J Autoimmunity 1988;1:469-481.

54. Sthoeger, ZM, Wakai M, Tse DB, Vinciguerra VP, Allen SL, Budman DR, Lichtman SM, Schulman P, Weiselberg LR, Chiorazzi N. Production of autoantibodies by CD5-expressing B lymphocytes from pa tients with chronic lymphocytic leukemia. J Exp Med 1989;169:255-268.

55. Borche L, Lim A, Binet JL, Dighiero G. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to productions of natural autoantibodies. Blood 1990;76:562-569.

56. Kipps TJ, Tomhave E, Chen PP, Carson DA. Autoantibody associated K light chain variable region gene expressed in chronic lymphocytic leukemia with little or no somatic mutation, implications for etiology and immunotherapy. J Exp Med 1988;167:840-852.

57. Kipps TJ, Tomhave E, Pratt LF, Duffy S, Chen PP, Carson DA. Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1989;86:5913-5917.

58. Humphries CG, Shen A, Kuziel WA, Capra JD, Blattner FR, Tucker PW. A new human immunoglobulin VH family preferentially rearranged in immature B-cell tumors. Nature 1988;331:446-^149.

59. Logtenberg T, Schutte MEM, Inghirami G, Berman JE, Gmelig-Meyling FHJ, Insel RA, Knowles DM, Alt FW. Immunoglobulin VH gene expression in human B cells lines and tumors: Biased VH expression in chronic lymphocytic leukemia. Int Immunol 1989;1:362-370.

60. Mayer R, Logtenberg T, Strauchin J, Dimitriu-Bona A, Mayer L, Mechanic S, Chiorazzi N, Borche L, Dighiero G, Mannheimer-Lory A, Diamond B, Alt F, Bona C. CD5 and immunoglobulin V gene expression in B-cell lymphomas and Chronic Lymphocytic Leukemia. Blood 1991;75:1518-1524.

61. Schroeder HW, and Dighiero G. Clues to the pathogenesis of CLL through analysis of B cell CLL antibody repertoires. Immunol Today 1994;15(6):288-294.

62. Fais F, Ghiotto F, Hashimoto S, Sellars B, Allen SL, Schulman P, Vinciguerra VP, Rai K, Rassenti L, Kipps TJ, Dighiero G, Schroeder HW, Ferrarini M, Chiorazzi N. Chronic Lymphocytic Leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J. Clin. Invest. 1998;102(8):1515-1525.

63. Ebeling SB, Schutte MEM, Akkermans Koolhaas E, Bloem AC, Gmelig-Meyling FHJ, Lotenberg T. Expression of members of the immunoglobulin VH3 gene families is not restricted at the level of individual genes in human chronic lymphocytic leukemia. Int Immunol 1992;4:313-320.

64. Shen AC, Humphries PW, Tucker PW, Blattner FR. Human heavy-chain gene family nonrandomly rearranged in familial chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1987;84:8563-8567.

65. Cai J, Humphries C, Lutz C, Tucker PW. Analysis of VH 251 gene mutation in chronic lymphocytic leukemia and normal B-cell subsets. Ann NY Acad Sci 1992;651:384-392.

66. Meeker TC, Grimaldi JC, O'Rourke R, Loeb J, Julius-son G, Einhorn S. Lack of detectable somatic hypermutation in the V region of Ig H chain gene of a human chronic B lymphocytic leukemia. J Immunol 1988;141:3994-3998.

67. Rassenti LZ, Kipps TJ. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia. J Exp Med 1993;177:1039-1046.

68. Deane M, Norton JD. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias. Eur J Immunol 1990;20:2209-2217.

69. Pritsch O, Magnac C, Dumas G, Egile C, Dighiero G. V gene usage by seven hybrids derived from CD5+ B-cell Chronic Lymphocytic Leukemia and displaying autoantibody activity. Blood 1993;82:3103-3112.

70. Kaushik A, Mayer R, Fidanza V, Zaghouani H, Lim

A, Bona C, and Dighiero G. Lyl and V-gene expression among hybridopas secreting natural autoantibody. J Autoimmunity 1990;3:687-700.

71. Dighiero G, Hart S, Lim A, Borche L, Levy R, Miller RA. Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas. Blood 1991;78:581-586.

72. Cleary ML, Meeker TC, Levy S, Lee E, Trela M, Sklar J, Levy R. Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell 1986;44:97-105.

73. Schroeder HW, Hillson JL, Perlmutter RM. Early restriction of the human antibody repertoire. Science 1987;238:791-793.

74. Schroeder HW, Wang JY. Preferential utilization of conserved immunoglobulin heavy chain variable gene segments during human fetal life. Proc Natl Acad Sci USA 1990;87:6146-6150.

© 2000 Elsevier Science B.V.All rights reserved.

Cancer and Autoimmunity

Y. Shoenfeld and M. E. Gershwin, editors

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment